In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

One of the most remarkable aspects of the populist alliance between Robert F. Kennedy Jr. and Donald Trump is that it puts ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

President-elect Donald Trump said he is tapping Robert F. Kennedy Jr., to run the Department of Health and Human Services, a ...

After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. | Trump's appointment follows his ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

The rapid progress in AI has also facilitated real-life applications within the pharmaceutical industry that may lead to ...